• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BIT
Click for more information
4.76% 2.0¢

BIOTRON LIMITED

Market Cap $18.04M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Biotron Limited is an Australia-based biotechnology company. The Company is primarily... Biotron Limited is an Australia-based biotechnology company. The Company is primarily engaged in the funding and management of intermediate and applied biotechnology research and development projects. The Company’s clinical programs include BIT225-001, BIT225-003, BIT225-004, BIT225-005, BIT225-006, BIT225-007 and BIT225-008. BIT225 is in mid-stage clinical development for treatment of HIV-1 and Hepatitis C virus (HCV) infections, with seven clinical trials completed. BIT225 is a HIV-1 Vpu protein inhibitor with the aim of inhibiting virus replication in cellular reservoirs. BIT225 is a viral assembly inhibitor that targets HCV p7 protein. In addition to the development of BIT225, the Company has a portfolio of preclinical antiviral programs developing drugs targeting a range of significant established and emerging viral diseases such as Dengue, Zika and Influenza virus.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
BIT
$10 Billion Deal
220 221 222
19/09/24 13K 6.4M
19/09/24 Last post  il duce Comments Created with Sketch.  13K  Views Created with Sketch.  6.4M 
BIT
Is Biotron a Scam and Sham? 		17/09/24 43 15K
17/09/24 Last post  Stickshift Comments Created with Sketch.  43  Views Created with Sketch.  15K 
BIT
What is the value of BIT-225?
2
16/09/24 61 18K
Metals & Mining SECTOR NEWS

Second round assay results shapes promising greenfields gold discovery at Claw Gold Project

Read More   right-arrow Created with Sketch.
BPM
20 Sep 2024
BPM MINERALS LIMITED
16/09/24 Last post  Scooterdog Comments Created with Sketch.  61  Views Created with Sketch.  18K 
BIT
Ann: BIT225-012 PHASE 2 COVID-19 CLINICAL TRIAL
2 3
09/09/24 120 40K
09/09/24 Last post  seetha Comments Created with Sketch.  120  Views Created with Sketch.  40K 
BIT
What will be the trigger?
2
06/09/24 60 13K
06/09/24 Last post  humpday Comments Created with Sketch.  60  Views Created with Sketch.  13K 
BIT
Ann: Full Year Statutory Accounts and Appendix 4E
2
06/09/24 91 25K
06/09/24 Last post  Phoenix101 Comments Created with Sketch.  91  Views Created with Sketch.  25K 
BIT
Class Action Incoming For Blatant Lies 		06/09/24 2 1.0K
06/09/24 Last post  humpday Comments Created with Sketch.  2  Views Created with Sketch.  1.0K 
BIT
Complete headline results for Commercial Deal, when?
4 5 6
02/09/24 317 81K
02/09/24 Last post  luxury Comments Created with Sketch.  317  Views Created with Sketch.  81K 

See All Discussions arrow Created with Sketch.

Timeline

BIT225-012 PHASE 2 COVID-19 CLINICAL TRIAL
06 Sep 09:37
 
Appendix 4G
30 Aug 08:06
 
Corporate Governance Statement
30 Aug 08:06
 
Full Year Statutory Accounts and Appendix 4E
30 Aug 08:05
 
Application for quotation of securities - BIT
15 Aug 11:05
 
Quarterly Activities/Appendix 4C Cash Flow Report
31 Jul 08:52
 
View More arrow Created with Sketch.

Featured News

EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Positive results highlight gold and lithium potential at Shoobridge
right-arrow Created with Sketch.
NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
(20min delay)
Last
2.0¢ 		Change
-0.001(4.76%) 		Mkt cap ! $18.04M
Open High Low Value Volume
2.0¢ 2.1¢ 2.0¢ $17.17K 857.4K

Buyers (Bids)

No. Vol. Price($)
4 502539 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 324673 3
View Market Depth
Last trade - 16.10pm 20/09/2024 (20 minute delay) ?
Last
2.0¢ 		  Change
-0.001 ( 4.76 %)
Open High Low Volume
2.0¢ 2.1¢ 2.0¢ 539582
Last updated 15.11pm 20/09/2024 ?
BIT (ASX) Chart

Top Stories

Auckland airport launches second round of equity raising, with $200M retail offer

Auckland International Airport Ltd is set to boost its coffers with a retail offer worth $200 million, which follows an earlier placement
Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off Harvey Norman shares were up +0.62% to $4.85/sh heading into lunchtime in Sydney on Wednesday – even as Echo Law's class action kicks off.
Essential Energy conference: Streamlining approvals key to the green energy transition WA Minister for Energy, the Environment and Climate Action Reece Whitby spoke at the RIU energy conference on Wednesday about state policies
Firetail executive changes set to propel development in Canada and Peru Firetail Resources Ltd has appointed former CEO Glenn Poole as managing director, while Brett Grosvenor has stepped into a non-executive role
HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix 88 Energy has posted news of a "significant contingent resource update" for Project Phoenix – but HotCopper users weren't sure.

Featured News

NEWS Positive results highlight gold and lithium potential at Shoobridge
right-arrow Created with Sketch.
NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.